HUP2100456A1 - Szemcsepp készítmény - Google Patents
Szemcsepp készítményInfo
- Publication number
- HUP2100456A1 HUP2100456A1 HU2100456A HUP2100456A HUP2100456A1 HU P2100456 A1 HUP2100456 A1 HU P2100456A1 HU 2100456 A HU2100456 A HU 2100456A HU P2100456 A HUP2100456 A HU P2100456A HU P2100456 A1 HUP2100456 A1 HU P2100456A1
- Authority
- HU
- Hungary
- Prior art keywords
- eye drop
- drop formulation
- formulation
- eye
- drop
- Prior art date
Links
- 239000003889 eye drop Substances 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2100456A HUP2100456A1 (hu) | 2021-12-28 | 2021-12-28 | Szemcsepp készítmény |
PCT/HU2022/050090 WO2023126636A1 (en) | 2021-12-28 | 2022-12-21 | Eye drop formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2100456A HUP2100456A1 (hu) | 2021-12-28 | 2021-12-28 | Szemcsepp készítmény |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP2100456A1 true HUP2100456A1 (hu) | 2023-08-28 |
Family
ID=89993490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU2100456A HUP2100456A1 (hu) | 2021-12-28 | 2021-12-28 | Szemcsepp készítmény |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP2100456A1 (hu) |
WO (1) | WO2023126636A1 (hu) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10231244A (ja) * | 1997-02-19 | 1998-09-02 | Newtec:Kk | 親水性包接複合体及びその製造方法 |
US7893040B2 (en) * | 2005-07-22 | 2011-02-22 | Oculis Ehf | Cyclodextrin nanotechnology for ophthalmic drug delivery |
CN101757621B (zh) * | 2008-11-28 | 2012-07-04 | 天津金耀集团有限公司 | 一种眼部抗炎的环糊精包合药物组合物 |
PT2616078T (pt) * | 2010-09-16 | 2020-03-31 | Shimoda Biotech Pty Ltd | Composições de fulvestrant e métodos de uso |
WO2012085671A2 (en) * | 2010-12-21 | 2012-06-28 | Omegatri As | Antioxidants in fish oil powder and tablets |
RU2494757C1 (ru) * | 2012-04-12 | 2013-10-10 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая фермент дезоксирибонуклеазу, альфа-фетопротеин и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия |
TW201902463A (zh) * | 2017-06-05 | 2019-01-16 | 瑞典商迪茲林製藥股份有限公司 | 左旋多巴輸注溶液 |
WO2019086366A1 (en) * | 2017-11-06 | 2019-05-09 | Dermalena Di Calderan Andrea | N-acetylcysteine and urea-based formulation for the treatment of dermatological disorders |
-
2021
- 2021-12-28 HU HU2100456A patent/HUP2100456A1/hu unknown
-
2022
- 2022-12-21 WO PCT/HU2022/050090 patent/WO2023126636A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023126636A1 (en) | 2023-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3585393A4 (en) | FORMULATIONS FOR EYE TREATMENTS | |
IL276918A (en) | Ophthalmic formulation | |
GB2568579B (en) | Ophthalmic drug compositions | |
EP3672598A4 (en) | OCULAR PHARMACEUTICAL COMPOSITIONS | |
GB201707462D0 (en) | Ocular compositions | |
IL284688A (en) | formulation | |
GB202007546D0 (en) | Formulation | |
EP3639726A4 (en) | SUBJECTIVE IL EXAMINATION SYSTEM | |
HUP2100456A1 (hu) | Szemcsepp készítmény | |
EP3590478C0 (en) | EYE DROPS APPLICATION | |
GB201913232D0 (en) | Aerosolisable formulation | |
GB201820021D0 (en) | Ocular hydrogel compositions | |
GB2595300B (en) | Novel Formulation | |
GB2595453B (en) | Novel Formulation | |
GB2599912B (en) | New formulation | |
EP3871660A4 (en) | EYE DROPS COMPOSITION WITH APTAMIN C AS THE ACTIVE SUBSTANCE | |
IL307849A (en) | Sutorsive formulation | |
IL308046A (en) | Alflizib formulation | |
GB202108165D0 (en) | Formulation | |
GB202107439D0 (en) | Formulation | |
GB202107203D0 (en) | Formulation | |
GB2587402B (en) | Formulation | |
GB202103970D0 (en) | Formulation | |
GB202102636D0 (en) | Formulation | |
GB202102408D0 (en) | Formulation |